Home News

Financial Results Nine month period 2019 - Video

Javier López-Belmonte, Vicepresident and CFO of Laboratorios Farmacéuticos ROVI presents the financial results for the first nine months of 2019.

Mon, 25/11/2019 - 11:12 0 min
Download related document
No votes yet
 
Related
The biosimilar Enoxaparin, a great opportunity for ROVI
“La historia de ROVI está unida a las heparinas desde nuestros inicios, por lo que este biosimilar de enoxaparina es una evolución lógica...
1 min
13/03/2017
Presentation on the biosimilar Enoxaparin of ROVI
0 min
13/03/2017
The Decentralised procedure used for the registration of ROVIs biosimilar of...
0 min
07/03/2017